Worksite Influenza Immunization Programs: Insight into the Implementation and Cost-Benefit

Advisory Committee on Immunization Practices (ACIP). (2003). Prevention and control of influenza. Morbidity Mortality Weekly Report, 52(RR08), 1–36.

Bridges C.B. , Meltzer M.I. , & Thompson W.W. (2001). Influenza vaccine for healthy working adults [Letter to editor]. Journal of the American Medical Association, 285, 292.

Bridges C.B. , Thompson W.W. , Meltzer M.I. , Reeve G.R. , Talamonti W.J. , Cox N.J. , Lilac N.J. , Lilac J.A. , Hall H. , Klimov A. , & Fukuda K. (2000). Effectiveness and cost-benefit of influenza vaccination of healthy working adults. Journal of the American Medical Association, 284, 1655–1663.

Burckel E. , Ashraf T. , de Sousa Filho J.P.G. , Neto E.F. , Guarino H. , Yauti C. , de Barros Barreto F. , & Champion L. (1999). Economic impact of providing workplace influenza vaccination. Pharmacoeconomics, 16, 563–576.

Burris J. , Olsen G.W. , Burlew M.M. , Steinberg M.E. , Stoltzfus J.A. , & Mandel J.H. (1999). Workplace influenza immunization update [Letter to editor]. Journal of Occupational and Environmental Medicine, 41, 415.

Byrnes G.B. , & Kelly H. (2001). Influenza vaccine for healthy working adults [Letter to editor]. Journal of the American Medical Association, 285, 290–291.

Couch R.B. (2000). Prevention and treatment of influenza. New England Journal of Medicine, 343, 1778–1787.

Cox J.N. , & Subbarao K. (1999). Influenza. Lancet, 354, 1277–1282.

Decisoneering. (2004). What is Monte Carlo simulation? Retrieved January 29, 2005 from, http://www.decisioneering.com/monte-carlo-simulation.html

Food and Drug Administration (FDA). (2004). Quick summary: Vaccines and Related Biological Products Advisory Committee. Retrieved August 9, 2004, from http://www.fda.gov/ohrms/dock-ets/ac/04/minutes/4020ml_quick%20summary.htm

Levy E. (1996). French economic evaluations of influenza and influenza vaccination. Pharmacoeconomics, 9(Suppl. 3), 62–66.

Nichol K.L. (2001a). Cost–benefit analysis of a strategy to vaccinate healthy working adults against influenza. Archives Internal Medicine, 161, 749–759.

Nichol K.L. (2001b). Influenza vaccine for healthy working adults [Letter to editor]. Journal of the American Medical Association, 285, 290.

Nichol K.L. , Lind A. , Margolis K.L. , Murdoch M. , McFadden R. , Hague M. , Magnan S. , & Drake M. (1995). The effectiveness of vaccination against influenza in healthy, working adults. New England Journal of Medicine, 333, 889–893.

Nichol K.L. , Mallon K.P. , & Mendelman P.M. (2003). Cost benefit of influenza vaccination in healthy, working adults: An economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine, 21, 2207–2217.

Nichol K.L. , Mendelman P.M. , Mallon K.P. , Jackson L.A. , Gorse G.J. , Belshe R.B. , Glezen W.P. , & Wittes J. (1999). Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults. Journal of the American Medical Association, 281, 137–144.

Olsen G.W. , Burris J.M. , Burlew M.M. , Steinberg M.E. , Patz N.V. , Stoltzfus J.A. , & Mandel J.H. (1998). Absenteeism among employees who participated in a workplace influenza immunization program. The Journal of Occupational and Environmental Medicine, 40, 311–316.

Postma M.J. , Jansema P. , van Genugten M.L.L. , Heijnen M.L.A. , Jager J.C. , & de Jong-van den Berg L.T.W. (2002). Pharmacoeconomics of influenza vaccination for healthy working adults. Drugs, 62, 1013–1024.

Principi N. , Esposito S. , Marchisio P. , Gasparini R. , & Crovari P. (2003). Socioeconomic impact of influenza on healthy children and their families. Pediatric Infectious Disease Journal, 22, S207–210.

Saxen H. , & Virtanen M. (1999). Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers. Pediatric Infectious Disease Journal, 18, 779–783.

Terebuh P. , Uyeki T. , & Fukuda K. (2003). Impact of influenza on young children and the shaping of United States influenza vaccine policy. Pediatric Infectious Disease Journal, 22, S231–235.

Treanor J.J. , Kotloff K. , Betts R.F. , Belshe R. , Newman F. , Iacuzio D. , Wittes J. , & Bryant M. (2000). Evaluation of trivalent, live, cold-adapted (LAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine, 18, 899–906.

Weingarten S. , Staniloff H. , Ault M. , Miles P. , Bamberger M. , & Meyer R.D. (1988). Do hospital employees benefit from the influenza vaccine? Journal of General Internal Medicine, 3(1), 32–37.

Wilde J.A. , McMillan J.A. , Serwint J. , Butta J. , O'Riordan M.A. , & Steinhoff M.C. (1999). Effectiveness of influenza vaccine in health care professionals. Journal of the American Medical Association, 281, 908–913.

Wood S.C. , Van Hung N. , & Schmidt S. (2000). Economic evaluations of influenza vaccination in healthy working-age adults. Pharmacoeconomics, 18, 173–183.